ProKidney Statistics

Total Valuation

ProKidney has a market cap or net worth of $898.99 million. The enterprise value is $599.25 million.

Market Cap	898.99M
Enterprise Value	599.25M

Important Dates

The last earnings date was Friday, May 10, 2024, before market open.

Earnings Date	May 10, 2024
Ex-Dividend Date	n/a

Share Statistics

ProKidney has 231.70 million shares outstanding. The number of shares has decreased by -0.96% in one year.

Shares Outstanding	231.70M
Shares Change (YoY)	-0.96%
Shares Change (QoQ)	-1.95%
Owned by Insiders (%)	6.73%
Owned by Institutions (%)	51.97%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 17.62

Current Ratio	17.62
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2,774.27

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-8.10%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$216,534
Employee Count	163
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, ProKidney has paid $4.77 million in taxes.

Income Tax	4.77M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -61.24% in the last 52 weeks. The beta is 1.11, so ProKidney's price volatility has been higher than the market average.

Beta (1Y)	1.11
52-Week Price Change	-61.24%
50-Day Moving Average	2.14
200-Day Moving Average	3.23
Relative Strength Index (RSI)	68.81
Average Volume (30 Days)	778,672

Short Selling Information

The latest short interest is 10.29 million, so 4.44% of the outstanding shares have been sold short.

Short Interest	10.29M
Short Previous Month	11.56M
Short % of Shares Out	4.44%
Short % of Float	n/a
Short Ratio (days to cover)	9.31

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-150.72M
Pretax Income	-30.53M
Net Income	-35.30M
EBITDA	-26.39M
EBIT	-30.52M
Earnings Per Share (EPS)	-$0.57

Full Income Statement

Balance Sheet

The company has $329.00 million in cash and $5.95 million in debt, giving a net cash position of $323.05 million or $1.39 per share.

Cash & Cash Equivalents	329.00M
Total Debt	5.95M
Net Cash	323.05M
Net Cash Per Share	$1.39
Equity / Book Value	-1.10B
Book Value Per Share	-4.73
Working Capital	320.86M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$98.72 million and capital expenditures -$34.17 million, giving a free cash flow of -$132.89 million.

Operating Cash Flow	-98.72M
Capital Expenditures	-34.17M
Free Cash Flow	-132.89M
FCF Per Share	-$2.18

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ProKidney does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.96%
Shareholder Yield	0.96%
Earnings Yield	-3.83%
FCF Yield	-14.41%

Dividend Details

Analyst Forecast

The average price target for ProKidney is $7.00, which is 80.41% higher than the current price. The consensus rating is "Buy".

Price Target	$7.00
Price Target Difference	80.41%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	Jul 12, 2022
Split Type	n/a
Split Ratio	1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1